Tag: ctDNA
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
By Kara Nyberg, PhD
Posted: June 24, 2020
New findings from the TRACERx lung study underscore the value of using circulating tumor DNA (ctDNA) to predict...
Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin...
Posted: April 16, 2020
As we know, molecular marker identification allows for more rational use of existing therapies. When markers can be identified more effectively...
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint...
By Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Posted: December 11, 2019
IN REFERENCE TO: Phallen J, Leal A, Woodward BD, et al. Early Noninvasive Detection of...
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
Improved Turnaround Times for Biopsy Results Matters More Than Type of Biopsy
By Dr. Edgardo S. Santos Castillero, MD, FACP
Posted: December 11, 2019
Regarding “Liquid Biopsy for Assessing...
